Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Abeona Therapeutics (ABEO) over the last 14 years, with Q3 2025 value amounting to -$14000.0.

  • Abeona Therapeutics' Change in Receivables rose 4814.81% to -$14000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3000.0, marking a year-over-year increase of 10036.99%. This contributed to the annual value of -$792000.0 for FY2024, which is 13880.45% down from last year.
  • According to the latest figures from Q3 2025, Abeona Therapeutics' Change in Receivables is -$14000.0, which was up 4814.81% from $13000.0 recorded in Q2 2025.
  • In the past 5 years, Abeona Therapeutics' Change in Receivables ranged from a high of $3.4 million in Q2 2023 and a low of -$3.0 million during Q1 2022
  • In the last 4 years, Abeona Therapeutics' Change in Receivables had a median value of -$20500.0 in 2024 and averaged -$127642.9.
  • Its Change in Receivables has fluctuated over the past 5 years, first skyrocketed by 24250.0% in 2023, then crashed by 43600.0% in 2024.
  • Over the past 4 years, Abeona Therapeutics' Change in Receivables (Quarter) stood at -$1.0 million in 2022, then soared by 102.0% to $20000.0 in 2023, then surged by 95.0% to $39000.0 in 2024, then crashed by 135.9% to -$14000.0 in 2025.
  • Its Change in Receivables stands at -$14000.0 for Q3 2025, versus $13000.0 for Q2 2025 and -$35000.0 for Q1 2025.